reSee.it - Related Video Feed

Since May 2020, Remdesivir has been linked to a 30% death rate among patients receiving the drug for 5 to 10 days in hospitals. In New York, 26.9% of Medicare-aged patients who received Remdesivir died. The Cardiovascular Toxicology Journal found in October 2020 that Remdesivir is cardiotoxic and can cause death of heart cells. Despite this, the FDA and NIH continue to approve and recommend Remdesivir as the only drug for hospitalized COVID-19 patients. The World Health Organization published in April of last year that Remdesivir leads to increased acute kidney failure compared to other drugs. Shockingly, the FDA recently authorized the use of Remdesivir for newborns and children up to 18 years old.

Most toothpaste contains fluoride, which is claimed to be a harmful endocrine disruptor. Fluoride allegedly replaces iodine in thyroid hormone, potentially leading to thyroid hormone dysfunction, even when thyroid hormone levels appear normal in tests. This is because the thyroid hormone may lack the necessary iodine molecule to function correctly. This could explain why some individuals experience thyroid disease symptoms despite having normal thyroid hormone levels.

Speaker 0: This is Prevenar, made by Pfizer. There are several products on the market, but the concept is the same. This is one of the studies that brought this product to market. Here’s what I want to show you. You’ll notice up here, this is the number of patients in the placebo group. This where my finger is is the control group that was treated, and then this is the placebo group. Notice how many there are. What it says is you need to treat forty two thousand two hundred forty patients with the vaccine Prevenar in order to prevent forty one cases of pneumonia. And they all get the benefits of the potential side effects of the drug. Let’s look at that quickly. Section 6.2 in the package insert, lymphadenopathy cyanosis in the pediatric population, anaphylaxis, hypotonia, reduced tone in kids that get this vaccine, skin and subcutaneous disorders, vascular disorders, etcetera. In this vaccine is polysorbate 80 and aluminum as an adjuvant. Aluminum neurotoxin. Of course, there’s section 13.1. The product has not been evaluated to see if it causes cancer or interferes with reproductive health. Pretty important information to know.

Ozempic, containing semaglutide, became a household name due to its weight loss effects, though it belongs to a class of drugs used for decades to treat type 2 diabetes. While diabetes treatments haven't gained similar recognition despite the high mortality rate, Ozempic's weight loss effects on celebrities propelled it into the spotlight. Clinical trials indicated that these drugs are the most effective weight loss drugs ever. Semaglutide mimics the GLP-1 hormone. Semaglutide is found in both Ozempic and Wegovy, but Wegovy is FDA approved for weight loss.

The speaker expresses shock upon learning that GLP-1 drugs like Wegovy and Ozempic are derived from lizard venom. They question whether people believe their weight and diabetes are due to a Gila monster venom deficiency, requiring them to inject venom weekly. The speaker is skeptical of the drugs' safety and effectiveness despite FDA approval, citing concerns about stomach paralysis and thyroid cancer risks. They claim to have educated the world about this venom-based drug after learning about it and being invited on shows to discuss it.

After 40 years of studying reproductive toxicology, I always refer to these studies when unsure about a drug. The findings are shocking, with numerous cases of pregnancy loss and severe malformations such as missing brains, skulls, and eyes, as well as rib abnormalities. If any of these issues are present in a reproductive toxicology study, I would never prescribe the drug under any circumstances.

Ozempic should not be allowed for weight loss because it causes a disproportionate loss of muscle mass. Losing muscle mass at a high rate is especially problematic for elderly patients, as it is difficult to regain. The weight loss induced by Ozempic is a starvation weight loss. This type of weight loss decreases the immune system, bone density, and muscle mass, ultimately decreasing longevity.

Since May 2020, Remdesivir has been linked to a 30% death rate among patients receiving the drug in hospitals for 5 to 10 days. In New York, 26.9% of Medicare-aged patients who received Remdesivir died. The Cardiovascular Toxicology Journal found in October 2020 that Remdesivir causes heart cell death and is cardiotoxic. However, the FDA and NIH continue to approve and recommend Remdesivir as the only drug for hospitalized COVID-19 patients, despite the World Health Organization's report in April of last year that it causes increased acute kidney failure. Shockingly, the FDA recently authorized the use of Remdesivir for newborns and children up to 18 years old.

Dr. Josef Duhring and Dr. Yosef (Doctor Yosef Duhring) discuss antidepressants and SSRIs, outlining perceived risks, data limitations, and long-term concerns, followed by practical guidance on tapering and contact information for a tapering clinic. Key side effects and risks cited - Common side effects: gastrointestinal issues (nausea, vomiting, diarrhea), changes in sleep (insomnia or drowsiness), headaches, nervousness, restlessness, dry mouth, sweating, tremors, sexual dysfunction, decreased libido, difficulty reaching orgasm, erectile dysfunction, appetite and weight changes (gain or loss). - Other reported effects: emotional blunting, feeling less like yourself, dizziness, balance issues (especially early in treatment), increased sweating, abnormal dreams. - Serious but rarer risks: suicidal thoughts or behaviors, particularly under age 25; serotonin syndrome (described as rare); heart rhythm changes at high doses with some SSRIs. - Behavioral effects: mania, psychosis, irritability, aggression; rare but potentially misdiagnosed as bipolar disorder; in some cases leading to escalation to lithium or antipsychotics. - Sleep and long-term effects: SSRI use diminishing sleep quality (less REM and deep sleep), resulting in fatigue and brain fog in long-term users. - Long-term data gaps: “there has never been a randomized control study that looked at them for over a year,” and “seventy percent of antidepressant users are on these drugs for two years or more.” Claims that there is no long-term data on sustained efficacy or safety beyond eight to twelve weeks. Efficacy and data concerns - Most drugs reach market based on eight-week studies; there is a reported two-point difference on a 52-point depression scale between the drug and placebo, which is described as clinically very low. - Outcomes most meaningful to patients (employment, relationships, life meaning) are not directly measured in standard trials, which focus on scale-based movement. - The claim is made that long-term efficacy remains unproven and that the long-term data are unavailable. Observations about prescription patterns and systemic factors - Online “pill mill” platforms allegedly enable easy access to SSRIs (Lexapro), sometimes without video chats, via online questionnaires, with rapid mail delivery. - The dose of prescription and patient interactions are affected by time constraints and economic incentives in healthcare delivery, leading to faster checklists and medication-based treatments rather than in-depth discussions of life context, relationships, or non-drug approaches. - An “unholy alliance” between the pharmaceutical industry and academic medicine is described: investigators may pursue drug trials for career advancement and publications funded by drug companies, potentially biasing conclusions in favor of medications. - The FDA’s stance is portrayed as influenced by this environment, with concerns about regulatory capture and inadequate critical evaluation of risks, including suicide risk data and withdrawal issues. Key long-term and withdrawal considerations - Long-term withdrawal: physicians are described as telling patients that antidepressant withdrawal is mild and resolves in two weeks, but tapering often requires one to two years to avoid withdrawal symptoms; many are tapered too quickly, leading to relapse or withdrawal challenges. - Tapers and recovery: the clinician reports patients improving emotionally during tapering, sometimes even before complete discontinuation; success depends on broader life health improvements (physical health, relationships, purpose) and careful, gradual reduction. Three major concerns observed with antidepressants (as described by Dr. Yosef) - They don’t work for many patients in the long term; diminished efficacy over time due to emotional blunting and neurochemical adaptation. - Behavioral and cognitive changes: potential for mania, psychosis, irritability, and misdiagnosis as bipolar disorder; risk of “drug-induced” psychiatric symptoms. - Toxicity and sleep: long-term blunting reduces emotional responsiveness; chronic sleep disruption and brain fog; long-term toxicity may underlie persistent symptoms after prolonged use. Clinical implications and guidance offered - For those considering antidepressants, emotions matter and should be explored beyond a chemical-imbalance narrative; discuss physical health, relationships, purpose, substances, and non-drug approaches (therapy, lifestyle changes) before relying on medication. - For those already on SSRIs, a careful, patient-guided taper is advised: slowly reduce dosages, use approaches such as liquid tapering to control precise reductions, and listen to one’s body to avoid withdrawal; a two-year taper may be necessary for many patients. - Coming off antidepressants can reveal or restore aspects of life and personality; benefits may appear during tapering as engagement and motivation return, but life circumstances must be addressed in parallel to avoid relapse. Contact information - Tapering clinic website: taperclinic.com (for patients in the U.S.; clinic claims to operate in about 15–16 states, covering roughly 70% of the population). - YouTube channel for further resources: Doctor Yosef (German version) with a free drug tapering training (about five hours) and guidance for working with a doctor. Speaker names - Dr. Yosef Duhring (referred to as Doctor Josef Duhring in the discussion) and Dr. Yosef (the same speaker) are cited; their experiences include FDA and industry roles and a tapering clinic specializing in antidepressant withdrawal and discontinuation.

The University of Stanford School of Medicine found that the average prescription drug has 398 side effects. If you take more than one drug, the number of side effects is unknown due to the combinations. This lack of knowledge makes it impossible to study all the potential side effects.

Three classes of drugs are described as toxic to the heart. First, fluoroquinolone antibiotics like Cipro and Levaquin can cause QT interval prolongation leading to lethal heart rhythms and aortic dissection, as well as palpitations, chest discomfort, and autonomic dysfunction. Second, nonsteroidal anti-inflammatories like ibuprofen and Naprosyn increase the risk of heart attack and stroke, raise blood pressure, and cause fluid retention, potentially leading to congestive heart failure. Third, stimulants like Adderall can cause abnormal heart rhythms and vasospasm, leading to heart attack or stroke. As a bonus, acetaminophen (Tylenol) lowers glutathione and causes liver damage. The recommendation is to avoid these drugs and address the root cause of the symptoms they are intended to treat.

Speaker 0: Formed consent Friday. Statins. What are in the package inserts? Let's look at the most common statin on the market, which is Crestor. Comes in generic, but here's the Crestor package insert. Let's go. This is designed to lower your cholesterol. Never mind that cholesterol isn't the cause of cardiovascular disease, but statins are a trillion dollar industry in The United States, and there's no turning back. Warnings and precautions. Myopathy rhabdomyolysis. That's muscle damage and injury. Immune mediated necrotizing myopathy. That's when your own immune system attacks your muscles. And hepatic dysfunction. That's liver problems as a result of the drug. But wait, there's more. Section 5.5. Interesting. Increases in hemoglobin a one c and fasting serum glucose levels. That's diabetes. In some instances, it says right in the package insert, these increases may exceed the threshold for the diagnosis of diabetes. So what they're saying is in many patients, my description, many, because I've seen it, statins increase blood sugar, increase hemoglobin a one c, and can actually lead to the development of type two diabetes. And by the way, what is the primary cause of cardiovascular disease? Metabolic dysfunction, I. E, insulin resistance, diabetes, and inflammation. Wait. I thought this drug was designed to reduce cardiovascular risk. Think about that. How about section 13.1, its ability to cause cancer? Well, there are studies done in animals to determine this, and in many cases, it can cause hepatocellular carcinoma. This is a study in mice. In studies of dog testicles, don't ask, it can cause spermatic giant cells, meaning it can cause inflammation and problems that can affect fertility. There you have it. About thirty percent of patients on statins will discontinue because of side effects. Does it save lives? Does it extend your life if you're on a statin? Actually, it can by about two or three days. Is it worth it? You decide. Informed consent. Now you know. Your comments are appreciated. Take care.

Ozempic carries a black box warning for increasing the risk of all forms of medullary thyroid cancer within twelve months of use. Oncologists are seeing new cancer patients on Ozempic and Wegovy developing breast cancer in under a year. Thousands of Americans are reporting eye-rotting diseases from using Ozempic and Wegovy. Ozempic and Wegovy are made from protein from the Gila monster lizard. According to the Smithsonian Institute, Gila monster venom is more deadly and toxic than a western diamondback rattlesnake. The speaker asks if people taking Ozempic and Wegovy believe they are overweight, diabetic, or have heart disease due to a Gila monster venom deficiency.

The Crestor package insert states the drug lowers cholesterol, though cholesterol may not be the cause of cardiovascular disease. Warnings include myopathy, rhabdomyolysis, immune-mediated necrotizing myopathy, and hepatic dysfunction. The insert also notes statins can increase hemoglobin A1c and fasting serum glucose levels, potentially leading to a diabetes diagnosis. The speaker claims statins can lead to type 2 diabetes, while the primary cause of cardiovascular disease is metabolic dysfunction, such as insulin resistance and diabetes. Animal studies suggest statins may cause hepatocellular carcinoma and problems affecting fertility. The speaker claims about 30% of patients discontinue statins due to side effects, and statins may extend life by about two or three days.

Ozempic has rapidly become a cultural phenomenon, with one in eight US adults having tried GLP-1 drugs. The company producing Ozempic is now valued higher than Coca-Cola and McDonald's combined. Online discussions mention side effects like Ozempic face, hair loss, and severe stomach problems, alongside reports suggesting potential benefits for fertility, Alzheimer's, and even shopping addiction. The speaker questions the complete truth about GLP-1 drugs and weight loss, and has spent months researching and attempting to obtain GLP-1 medication.

Pharmaceuticals cause a lot of liver damage. A great example is paracetamol or acetaminophen or Tylenol. It doesn't that actually dissolves liver tissue. So, I was with the Poisons Control, group in Colorado. They said during the holiday season their largest cases tend to be people that have overdosed on Tylenol or teenagers tried to take too much and maybe, like, attempted suicide or anything. But Tylenol and we have we have liver transplants and sometimes to people that have taken way too much Tylenol because Tylenol dissolves liver tissue. Tylenol dissolves liver tissue. During the holiday season, their largest cases tend to be people that have overdosed on Tylenol.

Ozempic causes appetite suppression, leading to weight loss, but also nausea and vomiting, causing some to stop usage. While effective and offering metabolic benefits from weight loss, it's very expensive, costing $1,300-$1,700 monthly. Weight returns upon cessation without lifestyle changes; it doesn't address behavior or habits. A significant downside is muscle loss, with 50% of weight lost being muscle, which is crucial for metabolism and overall health. Counteracting this requires increased protein intake and weight training. Metabolism may be slower post-treatment due to muscle loss. Long-term side effects are emerging, including a 450% increase in bowel obstruction and a 900% increase in pancreatitis. The drug addresses a symptom, not the cause, which is a toxic environment, lifestyle, and food system. Addressing obesity requires policy changes, agricultural and food system reform, and widespread education, which faces resistance from the large food industry.

Ivermectin is considered one of the safest medicines in history, with a wide dosing range and minimal side effects. A comprehensive review found no documented deaths associated with Ivermectin, even in cases of massive overdoses. The World Health Organization acknowledges that most side effects are minor and temporary, such as nausea, diarrhea, and blurry vision. As a physician, I find it to be a great medicine to work with due to its safety.

Ozempic carries a black box warning that it increases the risk of all forms of medullary thyroid cancer within twelve months of use. Oncologists are seeing new cancer patients on Ozempic and Wegovy developing breast cancer in under a year. People magazine reported thousands of Americans are experiencing eye-rotting diseases while using Ozempic and Wegovy. Ozempic and Wegovy are made from protein from the Gila monster lizard. The Smithsonian Institute told CNN that Gila monster venom is more deadly and toxic than a western diamondback rattlesnake. The speaker asks if people taking Ozempic and Wegovy believe they are overweight, diabetic, or have heart disease because they are Gila monster venom deficient.

Statins, like Crestor, are designed to lower cholesterol, though cholesterol may not be the primary cause of cardiovascular disease. Package inserts include warnings about myopathy, rhabdomyolysis, immune-mediated necrotizing myopathy, and hepatic dysfunction. Statins can increase hemoglobin A1c and fasting serum glucose levels, potentially leading to type 2 diabetes, which is linked to cardiovascular disease. Animal studies suggest a potential for hepatocellular carcinoma and, in dogs, spermatic giant cells, possibly affecting fertility. About 30% of patients discontinue statins due to side effects. Statins might extend life by approximately two or three days.

Pluvicto treatment involves radioactivity, potentially increasing cancer risk and causing fetal harm. To minimize risks, stay hydrated, urinate frequently, use contraception, and discuss radiation safety with your doctor both during and after treatment. Pluvicto may lead to low blood cell counts, kidney issues, and infertility. Contact your doctor if you experience weakness, pale skin, shortness of breath, easy bleeding or bruising, infection, or changes in urination. Common side effects include tiredness, dry mouth, nausea, appetite loss, and constipation.